Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13

Exposure of monocytes to pro-inflammatory cytokines or lipopolysaccharide (LPS) may induce synthesis and expression of tissue factor (TF). In this paper we have focused on the induction of TF-activity in human monocytes by the pro-inflammatory cytokines recombinant human interleukin 1 (rhIL-1 alpha) (rhIL-1 beta) (rhIL-6) and human tumour necrosis factor alpha (rhTNF-alpha), measured as procoagulant activity (PCA) in a microtitre plate-based clot assay. In addition we have studied the modulation of IL-1 alpha/beta induced TF-mRNA and PCA by rhIL-4, rhIL-10 and rhIL13. IL-1 alpha and IL-1 beta induced a concentration dependent increase in TF-activity. Neither IL-6 nor TNF-alpha gave rise to procoagulant activity at the concentrations tested (0.2-20 ng/ml). IL-4, IL-10 and IL-13, all effectively diminished IL-1 alpha/beta induced PCA, shown at the protein- and at the mRNA-level, while cell viability was unaffected. These results add to the previously demonstrated role of IL-4 and IL-10 as inhibitors of LPS-induced TF-activity, showing that these anti-inflammatory cytokines are not specific for LPS-activation but interfere with other stimulating substances such as IL-1, which may be involved in diseases where LPS is not present.     

Schistosoma mansoni: an enkephalinergic system that may participate in internal and host-parasite signaling

The present study is concerned with an opioid system in the human trematode Schistosoma mansoni, both as part of the endogenous chemical messenger system and as a tool in the parasite reaction to the host(s). A high-affinity opioid binding site was characterized in membrane suspensions prepared from adult worms. Scatchard analysis revealed a single class of receptors with a dissociation constant of 1.8 nM and a Bmax of 24.9 pmol/g protein for (D-Ala2, Met5)-enkephalin (DAME). The displacement experiments demonstrated that the most potent ligands were beta-endorphin, DAME, and met-enkephalin. These characteristics and the effects of various ions on DAME affinity suggest that S. mansoni has a delta-like opioid receptor, as previously described in other invertebrates. A met-enkephalin-like peptide was also characterized in a miracidial extract. Radioimmunoassay, reverse-phase HPLC, and bioassay by induction of cell conformational changes of human polymorphonuclear leukocytes revealed that the parasite peptide is very similar to authentic met-enkephalin. A met-enkephalin-like peptide was also shown to be present in adult worms and in their incubation medium. Taken together, these observations demonstrate the existence of a complete opiate system in S. mansoni. We discuss its role in molecular signaling within the parasite and in host-parasite interactions.     

Does age of the host affect growth rates of skeletal malignancies?

Statistical analysis of bone tumor growth rates as a function of age at initiation of radiation-induced skeletal malignancies in our animal colony indicated that the p value for an association between these parameters was <0.05, suggesting a correlation in beagle dogs. The youngest animals appeared to exhibit the most slowly growing tumors, and the trend was toward more rapidly growing tumors with increasing age. Less effective immune systems in older animals were invoked as a possible explanation of this relationship.     

Addison-Biermer disease combined with chronic posthemorrhagic iron-deficiency anemia (dimorphic anemias)

The paper reports 7 cases of dimorphic anemia, development of Addison-Biermer disease in preexisting chronic posthemorrhagic anemia. The authors consider some diagnostic and therapeutic aspects. It is thought valid to discontinue iron preparations prior to vitamin B12 therapy and to start them again upon the arising reticulocytic crisis.     

ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema

OBJECTIVE: To compare the tolerability of angiotensin-converting enzyme (ACE) inhibitors with that of angiotensin II (AII)-receptor blockers and the incidence of cough and angioedema associated with their use through review of published data. DATA SOURCES: References were identified through a MEDLINE search of articles published between January 1975 and April 1997. Bibliographies of pertinent references were also reviewed. RESULTS: Results of placebo-controlled and comparative trials of the AII blockers demonstrate that they are at least as effective as ACE inhibitors for hypertension, but exhibit an incidence of cough and absent or rare angioedema like that of placebo. CONCLUSIONS: In the 10 comparative trials described, all reported a lower incidence of cough with AII blockers than with ACE inhibitors. Angioedema was not reported in the comparative trials described.     

Breathing at low lung volumes and chest strapping: a comparison of lung mechanics

In six normal subjects forced expiratory flow rates increased progressively with increasing degrees of chest strapping. In nine normal subjects forced expiratory flow rates increased with the time spent breathing with expiratory reserve volume 0.5 liters above residual volume, the increase being significant by 30 s (P less than 0.01), and flow rates were still increasing at 2 min, the longest time the subjects could breathe at this lung volume. The increase in flow after low lung volume breathing (LLVB) was similar to that produced by strapping. The effect of LLVB was diminished by the inhalation of the atropinelike drug ipratropium. Quasistatic recoil pressures were higher following strapping and LLVB than on partial or maximal expiration, but the rise in recoil pressure was insufficient to account for all the observed increased in maximum flow. We suggest that the effects of chest strapping are due to LLVB and that both cause bronchodilatation.